bronchoscopy  on [**7-24**]   History of Present Illness: 58 yo M recently diagnosed with myeloproliferative/ myelodysplastic syndrome overlap syndrome, R thigh wound s/p failed/reversed skin graft, presents with fever and SOB.
He has been seen [**2148-7-17**] in clinic with WBC 79.000 16% blast.
he also had an echo that showed LVEF >75%, and small pericardial effusion, but no tamponade physicology.
PA pressures 24 mm HG .
At some point during his ED stay, there was a concern for a septic component, his blood pressure went down to 85/46, that he responded well to IV fluids.
Chest x ray revela fluid in the fissure and a sm right effusion.
His sats improved with 5L nasal cannula to 93-94 and then to 97-98 on 40% ventury and transfered to the [**Date Range 3242**] floor.
During the day on [**Date Range 3242**] floor, patient contiued to be tachypnea with RR in 30's, sat 98% on VM.
Patient receieved 1 U PRBC's on [**2148-7-17**] per OMR .
Pulmonology was consulted and felt that hypoxia was likely from fluid overload based on Chest CT findings.
Onc History: - presented on [**6-/2148**] with  a WBC of 69,000 with 10-15% blast forms - he was treated with hydra and ARAC.
- bone marrow biopsy showed 8% blast.
Family History: Older sister with some type of cancer, not very close  Physical Exam: VS: Tc 96.9 BP 100/60 Hr 112 Sats 98% on 50% Ventury mask.
Peak flow 150  RR 26-34: I/O's:  520/625 (after Lasix 20mg IV x2) Gen - Alert and oriented to Name, date, and "hosptial", m+ respiratory distress, using supraclavicular muscles and sitting bolt upright.
Pertinent Results: [**2148-7-18**]    7:28p   7.37/ 36/ 160 on Ventimask; FiO2%:50 [**2148-7-18**]    3:12p   7.34/40/84 Ventimask FiO2%:40 Lactate:1.9 [**2148-7-18**]    05:24a    7.37/41/67 .
PT: 14.2  PTT: 31.9  INR: 1.3 .
CK: 40  MB: 1  Trop-*T*: <0.01 .
Ca: 8.5 Mg: 1.6 P: 4.6 LDH: 611 UricA:6.5 .
...9.2    81 104.9>---< 52 ......27.1  N:26 Band:0 L:10 M:41 E:0 Bas:0 Atyps: 5 Myelos: 1 ***Blasts: 17*** .
[**2148-7-18**] 03:13AM 104.9*1 [**2148-7-17**] 01:48PM 79.1* [**2148-7-16**] 01:47PM 88.0* [**2148-7-15**] 01:45PM 73.7* [**2148-7-11**] 01:53PM 21.6* [**2148-7-8**] 08:58AM 4.3 .
Micro: Blood and Urine Cx NGTD .
[**2148-6-13**] Bone marrow Bx: expanded population of myelomonocytic precursor with increased myeloblasts (12% of total events) consistent with myeloproliferative/myelodysplastic syndrome .
Echo [**2148-7-17**]: EF > 75%.
PA pressures 24 mm hg .
# Respiratory Distress:  Patient was transferred from the [**Name10 (NameIs) 3242**] service to the [**Hospital Unit Name 153**] for persistent respiratory distress/increased work of breathing with RR in 30's and satting 98% on 50% oxygen by ventimask.
He had 2+ pitting pedal edema, crackles on lung exam and CXR with increase septal markings consistent with pulmonary edema and hyperinflation suggestive of emphysema.
Chest CT was done on ([**2148-7-22**]) arrival to the floor and showed improvement in previous lower lobe pneumonia, but worsening of right upper lobe ground- glass alveolar opacities and consolidation.
BAL was perfomed and all cultures were negative.
Repeat Chest Ct was perfomed on [**2148-7-29**] that showed interval improvment of the infiltrates.
His initial lactate was 4.3-->2.1 in the ED.
Although he was afebrile on arrival to the [**Hospital Unit Name 153**], blood, urine, and induced sputum was sent for cultures, as was a wound culture of his upper thigh.
Blood and urine were also sent for PCP and legionella.
On the floor, patient was started on Voriconazole for concern on fungal origin for his CT infiltrates.
CT chest showed improvement of infiltrates.
He also developed a left upper quadrant pain and CT abdomen showed possible splenic infaction, questionable splenic tear and no evidence of abscess.
His HCT was followed carefully and remained stable at time of discharge.
On [**2148-8-1**] after worsening of pain, U/S was performed and showed defect already seen on CT in the spleen.
Tumor lysis labs were checked Q day and were negative.
Patient's hematocrit remained stable and no transfusions were required during his [**Hospital Unit Name 153**] time.
Upon transfer to the flooor, it was decided to start chemotherapy with arac 40mg [**Hospital1 **] SC.
His counts trended down and have remained stable since then.
MRI was normal.
Medications on [**Hospital1 3242**]: Hydroxyurea [**2142**] mg PO BID Allopurinol 300 mg PO DAILY Ipratropium Bromide Neb 1 NEB IH Q4H  Order date: [**7-18**] @ 1853 Albuterol 0.083% Neb Soln 1 NEB IH Q3-4H:PRN Lorazepam 0.5 mg PO ONCE Duration: Aluminum-Magnesium Hydrox.-Simethicone 15-30 ml PO QID:PRN MethylPREDNISolone Sodium Succ 60 mg IV ONCE Azithromycin 250 mg PO Q24H Pantoprazole 40 mg PO Q24H Cefepime 2 gm IV Q8H Prednisone 10 mg PO BID Dolasetron Mesylate 12.5 mg IV Q8H:PRN Furosemide 20 mg IV ONCE Duration: 1 Doses Vancomycin HCl 1000 mg IV Q 12H Furosemide 20 mg IV ONCE Duration: 1 Doses   Discharge Medications: 1.
